Prof. Dr. med. A. Günther
(RA „Fibrotic Repair & Remodeling“)
Andreas Günther is board certified physician in Internal Medicine, Pulmonary and Critical Care and Sleep Medicine. He is full professor of Internal Medicine at the JLU, director of the Center for Interstitial and Rare Lung Diseases of the University Hospital in Giessen-Marburg, and Chief Physician / Medical Chair of the Lung Clinic Waldhof-Elgershausen, a 95-bed teaching hospital serving pulmonary patients only. Prof. Günther is active in several pharma-sponsored clinical trials, as well as in investigator-driven studies (in total 26). He serves as spokesman for the Clinical Research Unit “Pathomechanism and Therapy of Lung Fibrosis” (KFO 118, initially funded through DFG) and coordinates the European IPF Registry/Biobank (initially funded through EU FP7). He is also coordinator of the Discovery Area 2 “Cellular Surveillance” in the excellence cluster “Cardiopulmonary Institute” (funded by DFG), and coordinator of the Disease Area “Diffuse Parenchymal Lung Diseases” of the “University of Giessen and Marburg Lung Center” (funded through the Hessian excellency initiative LOEWE) and the “German Center for Lung Research” (DZL, funded through BMBF). Prof. Günther´s main areas of scientific interest include alveolar development and homeostasis, the alveolar surfactant system, mechanisms of epithelial injury including lysosomal and endoplasmic reticulum stress, and (re) activation of developmental pathways and alveolar progenitor cells during lung injury and repair. As of November 2018, he has published 173 original manuscripts in international, peer-reviewed journals, 51 invited reviews, editorials or commentaries, 12 book / 4 text book chapters. Prof. Günther received the Heisenberg stipend of the DFG, the Young Investigator Award of the German Society of Pneumology and the Oscar Medicine Prize (Oskar Helene Heim Foundation). Prof. Günther has profound experience as lecturer at the Giessen School of Medicine, especially in the field of Internal Medicine, lung diseases and pharmacotherapy. In addition, he also served as lecturer in the International Graduate Program “Molecular Biology and Medicine of the Lung” (MBML), where he was awarded twice as “Best Teacher of the Year”. Next to the long list of medical students, who have worked under his auspices for their medical thesis (n=60), Prof. Günther has also served as supervisor for a number of PhD students (n=15).
Prof. Dr. med. S. Herold, PhD
(RA „Imbalanced Inflammation & Infection“)
Susanne Herold is W3 Professor for Pulmonary Infections at the Justus-Liebig University, Coordinator of the Clinical Research Unit KFO309 (Virus-induced Lung Injury), Vice Speaker of the SFB-TR84, and Head of the Infectious Diseases Section at the Department of Medicine II of the University Hospital Giessen-Marburg. She is board certified in Internal Medicine, Infectious Diseases and Pulmonary Medicine. After receiving her MD (Dr. med.) title, she entered the MD/PhD track at the Department of Medicine II and graduated as PhD within the „Molecular Biology and Medicine of the Lung“ (MBML) program. Her research has been focused on the pathomechanisms of pneumonia-induced acute lung injury and repair for more than 15 years, reflected by many peer-reviewed publications and has delivered therapeutic approaches now being tested in investigator-initiated clinical phase II trials. Her national and international recognition resulted in acquisition of multiple collaborative project grants (SFB-TR84, SFB1021, KFO309), memberships in international scientific and clinical committees (e.g. for the European Respiratory Society and the American Thoracic Society), editorial board memberships, the deputy editor function of the Am J Respir Cell Mol Biol, and an appointment as Adjunct Professor at the Department of Pulmonary and Critical Care Medicine at Northwestern University of Chicago. She is vice president of the German Society of Infectious Diseases (DGI) and coordinator of the Disease Area “Pneumonia and ARDS” of the German Lung Center (DZL), and Area Speaker of the Excellence Cluster Cardio-Pulmonary Institute (CPI). She is a lecturer at the JLU, School of Medicine, with a focus on Pulmonary Medicine and Infectious Diseases, and in the MBML Graduate Program, and has been a supervisor of several Dr. med. students and PhD and MD/PhD students, out of which the majority graduated with summa cum laude.
Prof. Dr. med. T. Acker
(RA „Cancer Evolution & Progression“)
Institute for Neuropathology
University Hospital Gießen Marburg
D – 35392 Gießen
Vice Dean for Research
Faculty of Human Medicine
D – 35392 Gießen
Till Acker is full professor and director of the institute of neuropathology in Giessen. He is board certified in neuropathology. He is deputy speaker of MIRACUM, a consortium of 8 universities clinics funded by the Federal Ministry of Education and Research that aims at using biomedical techniques for big data analysis from health care to enhance patient-centered collaborative research as well as improve clinical care processes. Additionally, the consortium engages in strengthing biomedical informatics in research, teaching and training by setting up a joint master programme "Biomedical Informatics and Medical Data Science", summer schools as well as staff training programmes in medical data science for clinicians and medical researchers. At present, Till Acker is dean of research of the faculty of medicine in Giessen coordinating research funding and training programs for medical students and clinical/medical scientist. Till Acker serves as a reviewer and advisor for several national and international funding agencies as well various scientific journals including Nature, Nature Cell Biology, JEM, JNCI. Ongoing work focuses on the understanding of how stress-sensing mechanisms shape the aggressive tumor phenotype and regulate therapy resistance. His lab has pioneered work on the microenvironmental role of HIFs and the stress sensors PHDs in setting the hallmarks of cancer including metastasis and invasion, tumor stem cells, angiogenesis and proliferative signalling. Clinically, his group is particularly interested in the translational discovery and application of biomarkers through next generation sequencing techniques for the differential diagnosis and the prediction of therapy responses in brain tumors. He has published 69 peer-reviewed publications. Till Acker received a Max-Eder-Junior Research Group grant from the German Cancer Aid and is lecturer for Neuropathology at the Justus-Liebig University. He has been supervisor to 17 medical theses and 9 Ph.D. students.